Department of Pharmacy, The Moses H Cone Memorial Hospital, Greensboro, NC 27401-1020, USA.
Ren Fail. 2011;33(1):19-25. doi: 10.3109/0886022X.2010.536291.
Pediatric patients require special attention from pediatric pharmacists. This is particularly true for pediatric patients with chronic kidney disease (CKD) as the number of their medications and the complexity of their treatment increase with disease progression. However, there is paucity of information describing pediatric cognitive pharmacy services in this setting. The objective of this study is to identify the potential roles of a clinical pharmacist as a provider in a pediatric nephrology and hypertension clinic.
Pediatric patients (≤18 years of age) who chronically took at least one medication were consecutively enrolled at the University of North Carolina (UNC) Pediatric Nephrology and Hypertension Clinic from 1 August 2007 to 15 April 2008. Demographic information and the interventions performed during the clinic visit by a clinical pharmacist were examined.
Three hundred and seventy-four visits made in 283 participants were evaluated. The mean (SD) number of cognitive pharmacy interventions per patient was 2.3 (1.0) on the first visit, with medication counseling and verification of current medications comprising the most common activity (85%). The mean (SD) number of medications per patient was 5.7 (4.8) and of medications counseled per visit was 4.0 (3.4). Medication adherence was investigated in 141 (38%) visits. Pretransplant education on medications was performed in 3% of the patients. Discrepancies of medications were discovered in 12 of the 374 visits.
Pediatric cognitive pharmacy services to patients at the UNC pediatric nephrology clinic were feasible, which improved the quality of services and promoted better outcomes for these complex patients.
儿科患者需要儿科药剂师的特别关注。对于患有慢性肾脏病（CKD）的儿科患者尤其如此，因为随着疾病的进展，他们的药物数量和治疗的复杂性会增加。然而，在这种情况下，描述儿科认知药学服务的信息很少。本研究的目的是确定临床药师作为儿科肾脏病和高血压诊所提供者的潜在作用。
2007 年 8 月 1 日至 2008 年 4 月 15 日，连续招募在北卡罗来纳大学（UNC）儿科肾脏病和高血压诊所长期服用至少一种药物的儿科患者（≤18 岁）。检查了临床药师在诊所就诊期间进行的人口统计学信息和干预措施。
评估了 283 名参与者的 374 次就诊。每位患者的认知药学干预的平均（SD）次数为首次就诊时的 2.3（1.0），药物咨询和当前药物验证构成最常见的活动（85％）。每位患者的平均（SD）药物数量为 5.7（4.8），每次就诊时咨询的药物数量为 4.0（3.4）。在 141 次就诊（38％）中调查了药物依从性。对 3％的患者进行了移植前药物教育。在 374 次就诊中发现了 12 次药物差异。
UNC 儿科肾脏病诊所为患者提供的儿科认知药学服务是可行的，这提高了服务质量，并为这些复杂患者带来了更好的结果。
